DRMA, DRMAW · CIK 0001853816 · operating
Dermata Therapeutics, Inc. (DRMA) is a pharmaceutical preparations company incorporated in DE, listed on the Nasdaq. With a market capitalization of $4 million, Dermata Therapeutics, Inc. is a micro-cap company. The stock currently trades at $1.16, down 3.75% today, with a 52-week range of $1.16–$23.70. The company trades at a trailing P/E of 0.1x.
Fiscal years are as reported by the company and may not align with the calendar year. For example, Apple's FY 2024 ends in September 2024.
| Fiscal Year | EPS Diluted | EPS Basic | YoY | |
|---|---|---|---|---|
| 2024 | $-8.03 | $-8.03 | -200.7% | |
| 2023 | — | $-2.67 | -206.9% | |
| 2022 | — | $-0.87 | +64.2% | |
| 2021 | — | $-2.43 | — |